Beijing Tongren Hospital, Capital Medical University
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) | Adnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cervix disorder, endocrine system disorder, endometrial carcinoma, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, gonadal disorder, head and neck squamous cell carcinoma, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, small cell lung carcinoma, squamous cell carcinoma, transitional cell carcinoma, urothelial carcinoma, uterine disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT04152499 | |
| A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo | NonSegmental Vitiligo | Not yet recruiting | Phase 3 | 2026-10-08 | NCT07865312 | |
| A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy | Cranial Nerve Injuries, Craniocerebral Trauma, cranial nerve neuropathy, eye disorder, glaucoma, injury, nervous system disorder, nervous system injury, ocular hypertension, open-angle glaucoma, optic nerve disorder, traumatic optic neuropathy | Recruiting | Phase 2 | 2026-08-24 | NCT07777861 | |
| Diagnosis and Allergen Identification of Perioperative Anaphylaxis | Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, anaphylaxis, immune system disorder | Recruiting | Not stated | 2026-06-18 | NCT06793163 | |
| Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 1 | 2026-05-04 | NCT07040072 | |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis | Moderate to Severe Atopic Dermatitis | Not yet recruiting | Phase 2 | 2026-03-11 | NCT07465120 | |
| A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Leber hereditary optic neuropathy, Nutritional and Metabolic Diseases, cranial nerve neuropathy, eye disorder, hereditary disease, hereditary optic atrophy, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, optic atrophy, optic nerve disorder | Active, not recruiting | Phase 3 | 2026-02-12 | NCT07406854 | |
| Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification | Radiation Dose Reduction | Not yet recruiting | Not applicable | 2025-09-30 | NCT07199101 | |
| A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Not yet recruiting | Phase 3 | 2025-08-28 | NCT07146126 | |
| A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops | eye disorder, myopia, refractive error | Active, not recruiting | Phase 3 | 2025-07-30 | NCT06209320 | |
| An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 4 | 2023-11-09 | NCT05908695 |